0001104659-26-044425
SEC filingESCO Technologies Inc. entered into a $2.35 billion agreement to acquire Megger Group Limited, comprising $922 million in cash and 5.10 million shares of ESCO common stock, subject to regulatory approvals including CFIUS, HSR, and foreign investment clearances, with closing required by April 15, 2027.
This $2.35 billion acquisition of Megger Group Limited represents ESCO’s largest strategic move to date, significantly expanding its footprint in electrical test, measurement, and monitoring solutions—complementing its existing portfolio in sensing, filtration, and RF shielding. The all-cash-and-stock structure reflects ESCO’s intent to preserve balance sheet flexibility while aligning TBG AG’s interests through equity ownership and governance rights. Critical execution risk resides in the multi-jurisdictional regulatory path: CFIUS, DCSA, and foreign FDI reviews (including Belgium and Bulgaria) introduce timeline uncertainty and potential national security-related conditions or mitigation requirements. The April 15, 2027 closing deadline—with termination rights tied to unmet conditions—creates meaningful optionality for both parties but also pressure to resolve approvals efficiently. The shareholder agreement embeds durable influence for TBG: board representation tied to sustained equity ownership, phased liquidity via the 12-month lock-up (50% release at six months), and a hard 24.5% ownership cap absent ESCO Board consent—designed to prevent creeping control while enabling orderly exit. Financing is structured with layered contingencies: the $1.5B 'Best Efforts Facilities' serve as primary funding, backed by a $600M 'Backstop Facility' and a $975M 'Bridge Facility' to ensure closing certainty. Proceeds are strictly allocated to acquisition payment, refinancing, and transaction costs—leaving no ambiguity about capital deployment discipline. For investors, this deal materially increases scale and cross-selling potential but introduces integration complexity, regulatory overhang, and near-term dilution from 5.1M new shares.